Here, in vivo mouse models, DPP4 inhibition was obtained by the administration of Vildagliptin, a substance that is an inhibitor of DPP4 activity commonly used in treating diabetes mellitus type 2 [110]. The gene discussed is DPP4; the disease is diabetes mellitus.